Clinical Trial Update: A Placebo-controlled Study With an Extension Examining the Safety and Efficacy of Alefacept in Psoriatic Arthritis [Phase 2]

View source ↗

Summary

A Phase 2 placebo-controlled study of alefacept in psoriatic arthritis, with an extension to evaluate long-term safety and efficacy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psoriatic Arthritis

Drugs mentioned

• Alefacept (Alefacept)

Snippet

Sponsor: Astellas Pharma Inc | Conditions: Psoriatic Arthritis | Phase 2 | Status: COMPLETED